MCL1 and neoplasm: We demonstrated that ERp57 modulated radioresistance of laryngeal cancer cells by directly activating STAT3 and, in turn, triggered increased Mcl-1 expression, thereby contributing to tumor radioresistance of laryngeal cancer cells.